 |
 |
 |
Objective of the Issue
The company propose to utilise the Net Proceeds towards funding the following objects:
- Repayment/prepayment in full or part, of all or certain outstanding borrowings availed by the Company.
- General corporate purposes.
IPO Details, Price, Market Lot
| Sai Life Sciences IPO Details | |
| IPO Open Date | 11 December 2024 |
| IPO Close Date | 13 December 2024 |
| IPO Issue Size | 5,54,21,123 Shares (Aggregating up to ₹3,042.62 Cr) |
| Fresh Issue | 1,73,04,189 Shares (Aggregating up to ₹950.00 Cr) |
| Offer for Sale | 3,81,16,934 Shares (Aggregating up to ₹2,092.62 Cr) |
| Retail Portion | Not less than 35% of the offer |
| NII Portion | Not less than 15% of the offer |
| QIB Portion | Not more than 50% of the offer |
| Listing At | BSE, NSE |
| Sai Life Sciences IPO Price | |
| Face Value | ₹1 Per Share |
| IPO Price Band | ₹522 to ₹549 Per Share |
| Employee Discount | — |
| IPO Issue Type | Book Built Issue |
| Sai Life Sciences IPO Market Lot For Retail Investor | |
| No. of Shares Per Lot | 27 Shares |
| Minimum Lot Size | 1 Lot (27 Shares) |
| Minimum Amount (Cut-off price) | ₹14,823 |
| Maximum Lot Size | 13 Lots (351 Shares) |
| Maximum Amount (Cut-off price) | ₹1,92,699 |
| Sai Life Sciences IPO Market Lot For S-HNI | |
| No. of Shares Per Lot | 27 Shares |
| Minimum Lot Size | 14 Lots (378 Shares) |
| Minimum Amount (Cut-off price) | ₹2,07,522 |
| Maximum Lot Size | 67 Lots (1809 Shares) |
| Maximum Amount (Cut-off price) | ₹9,93,141 |
| Sai Life Sciences IPO Market Lot For B-HNI | |
| No. of Shares Per Lot | 27 Shares |
| Minimum Lot Size | 68 Lots (1836 Shares) |
| Minimum Amount (Cut-off price) | ₹10,07,964 |
IPO Date, Listing Date, Allotment Date
| Sai Life Sciences IPO Time Table (Tentative) | |
| IPO Open Date | 11 December 2024 |
| IPO Close Date | 13 December 2024 |
| Basis of Allotment Date | 16 December 2024 |
| Initiation of Refunds | 17 December 2024 |
| Credit of Share to Demat Account | 17 December 2024 |
| IPO Listing Date | 18 December 2024 |
Financial Report
| Period Ended | Assets (₹ in Crore) |
Revenue (₹ in Crore) |
P A T (₹ in Crore) |
Net Worth (₹ in Crore) |
Borrowings (₹ in Crore) |
| 30 Sept. 2024 | 2,476.78 | 693.35 | 28.01 | 1,044.75 | 764.49 |
| 31 March 2024 | 2,275.14 | 1,494.27 | 82.81 | 974.34 | 710.16 |
| 31 March 2023 | 2,186.65 | 1,245.11 | 9.99 | 887.29 | 699.23 |
| 31 March 2022 | 2,164.23 | 897.74 | 6.23 | 877.76 | 751.32 |
| Period Ended | 30 Sept. 2024 | 31 March 2024 | 31 March 2023 | 31 March 2022 |
| Assets | 2,476.78 | 2,275.14 | 2,186.65 | 2,164.23 |
| Revenue | 693.35 | 1,494.27 | 1,245.11 | 897.74 |
| P A T | 28.01 | 82.81 | 9.99 | 6.23 |
| Net Worth | 1,044.75 | 974.34 | 887.29 | 877.76 |
| Borrowings | 764.49 | 710.16 | 699.23 | 751.32 |
| Amount in ₹ Corre | ||||
Company Promotor & Promotor’s Holding
| Pre Issue Promotor Holding | 40.48% |
| Post Issue Promotor Holding | 35.10% |
Company Address
Sai Life Sciences Limited
Plot No. DS-7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Malkajgiri District, Hyderabad-500078
Phone: +9140 6815 6000
Email: investors@sailife.com
Website: https://www.sailife.com/
IPO Registrar, Lead Manager, Prospectus
| Sai Life Sciences IPO Prospectus |
| Sai Life Sciences IPO Registrar |
| Kfin Technologies Limited |
| Sai Life Sciences IPO Lead Manager |
|